|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/00 |
| (11) | Number of the document | 2525824 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11735264.1 |
| Date of filing the European patent application | 2011-01-21 | |
| (97) | Date of publication of the European application | 2012-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/022125 |
| Date | 2011-01-21 |
| (87) | Number | WO 2011/091305 |
| Date | 2011-07-28 |
| (30) | Number | Date | Country code |
| 336478 P | 2010-01-22 | US |
| (72) |
GIACCIA, Amato J., US
RANKIN, Erinn Bruno, US
COCHRAN, Jennifer R., US
JONES, Douglas, US
KARIOLIS, Mihalis, US
FUH, Katherine, US
MIAO, Yu, US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170 3rd Floor, Main Quad P.O. Box 20386, Stanford CA 94305-2038,
US
|
| (54) | INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY |
| INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY |